SCHEMBL23767499

SCHEMBL23767499

CC(C)c1nc2cnc(I)cc2n1I

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CCNT1 O60563 1/20 0.31
CDK9 P50750 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24306195 0.87 CCNT1 (0.33) CCNT1CDK9
SCHEMBL23767660 0.75 LMNA (0.36) CCNT1CDK9
SCHEMBL24305933 0.71 CNR2 (0.36) CCNT1CDK9
SCHEMBL24306078 0.70
SCHEMBL24306125 0.67 CNR2 (0.36) CCNT1CDK9
SCHEMBL23767411 0.66 LMNA (0.30)
SCHEMBL24306147 0.66
SCHEMBL13188083 0.61 KDM4E (0.51)
SCHEMBL24665784 0.61 GABRA1 (0.35)
SCHEMBL18850827 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021160127-A1 HETEROCYCLIC GLP-1 AGONISTS GASHERBRUM BIO, INC. (US) 2021-08-19 WO disclosed